Organometallic compound, organic light-emitting device including the organometallic compound, and apparatus including the organic light-emitting device

US12201016B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12201016-B2
Application numberUS-201916669208-A
CountryUS
Kind codeB2
Filing dateOct 30, 2019
Priority dateMar 13, 2019
Publication dateJan 14, 2025
Grant dateJan 14, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are an organometallic compound, an organic light-emitting device including the organometallic compound, and an apparatus including the organic light-emitting device. The organometallic compound is represented by Formula 1: M 11 (L 11 ) n11 (L 12 ) n12   <Formula 1> In Formula 1, L 11 is a ligand represented by Formula 1-1, which is explained in the specification:

First claim

Opening claim text (preview).

What is claimed is: 1. An organometallic compound represented by Formula 1: M 11 (L 11 ) n11 (L 12 ) n12 ,  <Formula 1> wherein, in Formula 1, M 11 is selected from a first-row transition metal, a second-row transition metal, and a third-row transition metal of the Periodic Table of Elements, L 11 is a ligand represented by Formula 1-1, L 12 is selected from a monodentate ligand and a bidentate ligand, n11 is 1, and n12 is selected from 0, 1, and 2: wherein, in Formula 1-1, X 11 to X 13 are each a single bond, Y 11 , Y 12 , and Y 13 are each C, Y 14 is N, T 11 to T 14 are each a single bond, ring A 12 , ring A 13 , and ring A 15 to ring A 20 are each a benzene group, R 11 to R 20 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazine group, a hydrazone group, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 7 -C 60 alkyl aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted C 2 -C 60 alkyl heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —C(Q 1 )(Q 2 )(Q 3 ), —Si(Q 1 )(Q 2 )(Q 3 ), —B(Q 1 )(Q 2 ), —N(Q 1 )(Q 2 ), —P(Q 1 )(Q 2 ), —C(═O)(Q 1 ), —S(═O)(Q 1 ), —S(═O) 2 (Q 1 ), —P(═O)(Q 1 )(Q 2 ), and —P(═S)(Q 1 )(Q 2 ), b11 is 3, b12 and b13 are each independently an integer from 1 to 3, b14 is 4, b15 to b20 are each independently an integer from 1 to 4, Q 1 to Q 3 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazine group, a hydrazone group, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a C 1 -C 60 alkyl group substituted with at least one selected from deuterium, —F, a cyano group, a C 1 -C 60 alkyl group, a phenyl group, and a biphenyl group, a C 6 -C 60 aryl group substituted with at least one selected from deuterium, —F, a cyano group, a C 1 -C 10 alkyl group, a phenyl group, and a biphenyl group, and a C 1 -C 60 heteroaryl group substituted with at least one selected from deuterium, —F, a cyano group, a C 1 -C 10 alkyl group, a phenyl group, and a biphenyl group, *1 to *4 each indicate a binding site to M 11 , a group represented by  is a group represented by Formula 3-11, and a group represented by  is represented by Formula 3-41: wherein in Formulae 3-11 and 3-41, R 11a , R 11b , and R 11c are each independently the same as defined in connection with R 1 in Formula 1-1, and R 11a , R 11b , and R 11c do not bond to each other to form a fused ring, and R 14a , R 14b , R 14c , and R 14d are each independently the same as defined in connection with R 14 in Formula 1-1, and wherein in Formulae 1-1, 3-11, and 3-41, * and *′ each indicate a binding site to a neighboring atom. 2. The organometallic compound of claim 1 , wherein M 11 is selected from platinum (Pt), palladium (Pd), copper (Cu), silver (Ag), gold (Au), rhodium (Rh), iridium (Ir), ruthenium (Ru), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), and thulium (Tm). 3. The organometallic compound of claim 1 , wherein a group represented by  is a group represented by Formula 3-21, and a group represented by  is a group represented by Formula 3-31 wherein, in Formulae 3-21 and 3-31, *, *′, and *″ each indicate a binding site to a neighboring atom, R 12a , R 12b , and R 12c are each independently the same as defined in connection with R 12 in Formula 1-1, and R 13a , R 13b , and R 13c are each independently the same as defined in connection with R 13 in Formula 1-1. 4. The organometallic compound of claim 1 , wherein R 11 to R 20 are each independently selected from: hydrogen, deuterium, —F, —Cl, —Br, —I, a cyano group, a C 1 -C 20 alkyl group, and a C 1 -C 20 alkoxy group; a C 1 -C 20 alkyl group and a C 1 -C 20 alkoxy group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a cyano group, a phenyl group, a biphenyl group, and a terphenyl group; a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a biphenyl group, a terphenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentacenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, a silolyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an indolyl group, an isoindolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a benzoisoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a benzoquinoxalinyl group, a quinazolinyl group, a benzoquinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, a benzosilolyl group, a benzothiazolyl group, a benzoisothiazolyl group, a benzoxazolyl group, a benzoisoxazolyl group, a triazolyl group, a tetrazolyl group, a thiadiazolyl group, an oxadiazolyl group, a triazinyl group, a carbazolyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a dibenzosilolyl group, a

Assignees

Inventors

Classifications

  • comprising refractive means, e.g. lenses · CPC title

  • OLEDs or polymer light-emitting diodes [PLED] · CPC title

  • H10K85/346Primary

    comprising platinum · CPC title

  • C09K11/06Primary

    containing organic luminescent materials · CPC title

  • Triplet emission · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12201016B2 cover?
Provided are an organometallic compound, an organic light-emitting device including the organometallic compound, and an apparatus including the organic light-emitting device. The organometallic compound is represented by Formula 1: M 11 (L 11 ) n11 (L 12 ) n12   <Formula 1> In Formula 1, L 11 is a ligand represented by Formula 1-1, which is explained in the specification:
Who is the assignee on this patent?
Samsung Display Co Ltd
What technology area does this patent fall under?
Primary CPC classification H10K85/346. Mapped technology areas include Electricity.
When was this patent published?
Publication date Tue Jan 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).